Tag: year¹
Inventiva publishes its preliminary financial information for the 2023 fiscal year¹ and provides an update on its NATiV3 clinical study – 02/15/2024 at 10:35 p.m.
Daix (France), Long Island City (New York, United States), February 15, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a biopharmaceutical company specializing in the clinical development of…